NTRR Joint Venture Offers New Antimicrobial Solutions to Embattled Colorado Cannabis Growers
April 07 2015 - 7:21AM
Business Wire
As testing continues in Colorado on horticultural products
marketed by Neutra Corp. (OTCBB:NTRR) and its joint venture
partner, Surface to Air Solutions (S2O2), the companies are already
receiving a great deal of interest from cannabis growers in the
state. In response, each Friday in April, S2O2 will conduct
educational information sessions on its suite of antimicrobial
alternatives to pesticides, hosted by respected cultivation
organization Denver Consulting Group.
Last month, S2O2 signed letter of intent with Denver
Consulting Group to test and demonstrate the efficacy of
its horticultural product suite at the company’s indoor
growing operations in the state.
“These open information sessions are the perfect way to spread
the word on these products before the official testing cycle is
complete,” said NTRR CEO Chris Brown. “We have been blown away by
the response to these products’ potential for the cannabis
industry. Growers are ready for real, effective alternatives to
pesticides for indoor cultivation.”
NTRR formed the joint venture with S2O2 last year to market
novel and ideal solutions to growers that are concerned about
contamination of their crops by microbes, molds, fungus and other
pests. The companies are marketing a suite of products that
includes an antimicrobial surface treatment, a nutritional plant
tonic and an air-scrubbing hydroxyl generator capable of keeping
growing facilities sterile without the use of harsh chemicals.
With interest rising and the results of its lab testing to be
completed once the 90-day testing period is complete, NTRR and its
joint venture partner are expecting a highly successful commercial
launch for the products, which are currently being tested in
Colorado, California and Canada.
About Neutra Corp.
Neutra Corp. is a healthy lifestyle company that specializes in
the development and marketing of natural wellness solutions,
including cannabis-related products. By providing a variety of new
technologies designed to ensure safer, more reliable access to
cannabis in approved markets, Neutra Corp. plans to compete
alongside GW Pharmaceuticals (OTCBB: GWPRF), INSYS Therapeutics,
Inc. (NASDAQ: INSY) and ENDEXX Corp. (OTCBB: EDXC), delivering
technological advancements in the cultivation and processing of
cannabis in approved markets. For investing information and
performance data, please visit www.neutracorp.com.
Notice Regarding Forward-Looking Statements
Safe Harbor Statement under the Private Securities Litigation
Reform Act of 1995: This news release contains forward-looking
information within the meaning of Section 27A of the Securities Act
of 1933, as amended, and Section 21E of the Securities Exchange Act
of 1934, as amended, including statements that include the words
“believes,” “expects,” “anticipate” or similar expressions. Such
forward-looking statements involve known and unknown risks,
uncertainties and other factors that may cause the actual results,
performance or achievements of the Company to differ materially
from those expressed or implied by such forward-looking statements.
In addition, description of anyone’s past success, either financial
or strategic, is no guarantee of success. This news release speaks
as of the date first set forth above and the Company assumes no
responsibility to update the information included herein for events
occurring after the date hereof.
Neutra Corp.Chris Brown, 813-367-2041President and
CEOinfo@neutracorp.com
Neutra (PK) (USOTC:NTRR)
Historical Stock Chart
From Jul 2024 to Jul 2024
Neutra (PK) (USOTC:NTRR)
Historical Stock Chart
From Jul 2023 to Jul 2024